Glenmark Launches Oral Antiviral COVID-19 Medication in India, an Industrial Info Market Brief
Glenmark Launches Oral Antiviral COVID-19 Medication in India, an Industrial Info Market Brief
Attachment: Map
Indian pharma major, Glenmark Pharmaceuticals Limited said it has launched an antiviral tablet - Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 symptoms.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
